vs

Side-by-side financial comparison of CPS TECHNOLOGIES CORP (CPSH) and Profound Medical Corp. (PROF). Click either name above to swap in a different company.

CPS TECHNOLOGIES CORP is the larger business by last-quarter revenue ($8.2M vs $6.0M, roughly 1.4× Profound Medical Corp.). CPS TECHNOLOGIES CORP runs the higher net margin — 0.2% vs -136.8%, a 136.9% gap on every dollar of revenue.

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

CompuGroup Medical SE & Co. KGaA is a German publicly listed software company based in Koblenz that develops and offers software for the healthcare sector. It produces cloud-based and digital application software to support medical and organizational activities in doctors' practices, pharmacies, medical laboratories and hospitals. According to its own figures, the company employed more than 9,200 people worldwide in 2022, and has over 1.6 million users in 56 countries. CompuGroup Medical shar...

CPSH vs PROF — Head-to-Head

Bigger by revenue
CPSH
CPSH
1.4× larger
CPSH
$8.2M
$6.0M
PROF
Higher net margin
CPSH
CPSH
136.9% more per $
CPSH
0.2%
-136.8%
PROF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPSH
CPSH
PROF
PROF
Revenue
$8.2M
$6.0M
Net Profit
$12.6K
$-8.2M
Gross Margin
14.9%
66.8%
Operating Margin
-1.2%
-123.3%
Net Margin
0.2%
-136.8%
Revenue YoY
38.3%
Net Profit YoY
101.3%
EPS (diluted)
$0.00
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSH
CPSH
PROF
PROF
Q4 25
$8.2M
$6.0M
Q3 25
$8.8M
$5.1M
Q2 25
$8.1M
$2.0M
Q1 25
$7.5M
$2.3M
Q4 24
$5.9M
Q3 24
$4.2M
Q2 24
$5.0M
Q1 24
$5.9M
Net Profit
CPSH
CPSH
PROF
PROF
Q4 25
$12.6K
$-8.2M
Q3 25
$208.0K
$-8.0M
Q2 25
$103.8K
$-15.7M
Q1 25
$96.0K
$-10.7M
Q4 24
$-995.2K
Q3 24
$-1.0M
Q2 24
$-954.3K
Q1 24
$-143.2K
Gross Margin
CPSH
CPSH
PROF
PROF
Q4 25
14.9%
66.8%
Q3 25
17.1%
77.7%
Q2 25
16.5%
81.7%
Q1 25
16.4%
79.2%
Q4 24
-4.6%
Q3 24
-12.3%
Q2 24
-4.6%
Q1 24
15.3%
Operating Margin
CPSH
CPSH
PROF
PROF
Q4 25
-1.2%
-123.3%
Q3 25
3.1%
-176.2%
Q2 25
1.7%
-696.9%
Q1 25
1.7%
-477.0%
Q4 24
-22.2%
Q3 24
-35.0%
Q2 24
-26.1%
Q1 24
-4.4%
Net Margin
CPSH
CPSH
PROF
PROF
Q4 25
0.2%
-136.8%
Q3 25
2.4%
-157.7%
Q2 25
1.3%
-792.3%
Q1 25
1.3%
-458.1%
Q4 24
-16.8%
Q3 24
-24.6%
Q2 24
-19.0%
Q1 24
-2.4%
EPS (diluted)
CPSH
CPSH
PROF
PROF
Q4 25
$0.00
$0.27
Q3 25
$0.01
$0.26
Q2 25
$0.01
$0.52
Q1 25
$0.01
$0.36
Q4 24
$-0.07
Q3 24
$-0.07
Q2 24
$-0.07
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSH
CPSH
PROF
PROF
Cash + ST InvestmentsLiquidity on hand
$13.2M
$59.7M
Total DebtLower is stronger
$4.5M
Stockholders' EquityBook value
$24.6M
$66.4M
Total Assets
$29.5M
$77.5M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSH
CPSH
PROF
PROF
Q4 25
$13.2M
$59.7M
Q3 25
$4.3M
$24.8M
Q2 25
$3.4M
$35.2M
Q1 25
$3.0M
$46.4M
Q4 24
$4.3M
Q3 24
$5.7M
Q2 24
$7.1M
Q1 24
$8.7M
Total Debt
CPSH
CPSH
PROF
PROF
Q4 25
$4.5M
Q3 25
$4.5M
Q2 25
$4.5M
Q1 25
$4.5M
Q4 24
$8.1K
Q3 24
$20.1K
Q2 24
$31.9K
Q1 24
$43.5K
Stockholders' Equity
CPSH
CPSH
PROF
PROF
Q4 25
$24.6M
$66.4M
Q3 25
$15.1M
$32.1M
Q2 25
$14.9M
$39.3M
Q1 25
$14.7M
$50.8M
Q4 24
$14.5M
Q3 24
$15.4M
Q2 24
$16.4M
Q1 24
$17.3M
Total Assets
CPSH
CPSH
PROF
PROF
Q4 25
$29.5M
$77.5M
Q3 25
$20.4M
$42.3M
Q2 25
$19.4M
$49.7M
Q1 25
$19.2M
$60.9M
Q4 24
$18.9M
Q3 24
$19.2M
Q2 24
$20.1M
Q1 24
$21.2M
Debt / Equity
CPSH
CPSH
PROF
PROF
Q4 25
0.07×
Q3 25
0.14×
Q2 25
0.11×
Q1 25
0.09×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSH
CPSH
PROF
PROF
Operating Cash FlowLast quarter
$243.6K
$-6.6M
Free Cash FlowOCF − Capex
$-487.0K
FCF MarginFCF / Revenue
-5.9%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
19.34×
TTM Free Cash FlowTrailing 4 quarters
$-479.6K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSH
CPSH
PROF
PROF
Q4 25
$243.6K
$-6.6M
Q3 25
$1.1M
$-9.6M
Q2 25
$649.3K
$-13.7M
Q1 25
$-1.3M
$-8.3M
Q4 24
$-3.5M
Q3 24
$-1.2M
Q2 24
$-1.0M
Q1 24
$128.9K
Free Cash Flow
CPSH
CPSH
PROF
PROF
Q4 25
$-487.0K
Q3 25
$876.8K
Q2 25
$476.4K
Q1 25
$-1.3M
Q4 24
$-4.5M
Q3 24
$-1.3M
Q2 24
$-1.6M
Q1 24
$-134.5K
FCF Margin
CPSH
CPSH
PROF
PROF
Q4 25
-5.9%
Q3 25
10.0%
Q2 25
5.9%
Q1 25
-17.9%
Q4 24
-75.3%
Q3 24
-29.8%
Q2 24
-31.8%
Q1 24
-2.3%
Capex Intensity
CPSH
CPSH
PROF
PROF
Q4 25
8.9%
Q3 25
2.0%
Q2 25
2.1%
Q1 25
1.2%
Q4 24
16.8%
Q3 24
1.9%
Q2 24
11.0%
Q1 24
4.5%
Cash Conversion
CPSH
CPSH
PROF
PROF
Q4 25
19.34×
Q3 25
5.05×
Q2 25
6.25×
Q1 25
-13.05×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons